文献速递其他结缔组织病

系统性硬化症血清蛋白谱大规模特征:与血细胞转录组比较及与皮肤/肺纤维化的相关性

Large-Scale Characterization of Systemic Sclerosis Serum Protein Profile: Comparison to Peripheral Blood Cell Transcriptome and Correlations With Skin/Lung Fibrosis.
PubMed 文献 · Arthritis Rheumatol · 2021-02-28

该研究对66例弥漫性皮肤型系统性硬化症(dcSSc)患者和66名年龄性别匹配健康对照的230种血清蛋白进行了检测,并同步进行全血基因表达分析。仅14个基因在血清蛋白和全血RNA中显示同向差异表达。

要点

  • dcSSc患者血清蛋白谱与健康对照显著不同,涉及纤维化和免疫细胞黏附/渗出相关蛋白。
  • 可溶性表皮生长因子受体水平降低与MRSS负相关最强,可预测MRSS随时间变化。
  • 癌抗原15-3水平升高与更严重的ILD相关(力肺活量降低、高分辨率CT疾病活动评分更高)。

核心结论

  • 弥漫性皮肤型系统性硬化症具有独特的血清蛋白谱,纤维化及免疫细胞黏附/渗出相关蛋白显著失调。
  • 大多数血清蛋白的差异表达可能起源于外周血细胞之外。

研究设计与样本

  • 研究纳入66例基线dcSSc患者(平均病程2.3年,均有ILD,未用免疫抑制剂)和66名年龄性别匹配健康对照。
  • 检测230种蛋白(含细胞因子和趋化因子),并同步进行全血基因表达谱分析。

主要发现

  • 可溶性表皮生长因子受体在dcSSc中显著下调,与MRSS负相关最强,可预测MRSS随时间变化。
  • α1-抗糜蛋白酶在dcSSc中显著上调,与MRSS正相关最强。
  • 癌抗原15-3水平较高与更严重的ILD相关(力肺活量降低、高分辨率CT疾病活动评分更高)。

临床怎么用

  • 可溶性表皮生长因子受体和α1-抗糜蛋白酶可能作为dcSSc皮肤纤维化严重程度及进展的血清标志物。
  • 癌抗原15-3水平或有助于评估dcSSc相关ILD的严重程度。

局限性

  • 样本量有限(66例患者),且所有患者均有ILD并未使用免疫抑制剂,结论外推需谨慎。
  • 横断面设计为主,血清蛋白与基因表达一致性低,机制推断受限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To provide a large-scale assessment of serum protein dysregulation in diffuse cutaneous systemic sclerosis (dcSSc) and to investigate serum protein correlates of SSc fibrotic features. METHODS: We investigated serum protein profiles of 66 participants with dcSSc at baseline who were enrolled in the Scleroderma: Cyclophosphamide or Transplant Trial and 66 age- and sex-matched healthy control subjects. A panel of 230 proteins, including several cytokines and chemokines, was investigated. Whole blood gene expression profiling in concomitantly collected samples was performed. RESULTS: Among the participants with dcSSc, the mean disease duration was 2.3 years. All had interstitial lung disease (ILD), and none were being treated with immunosuppressive agents at baseline. Ninety proteins were differentially expressed in participants with dcSSc compared to healthy control subjects. Similar to previous global skin transcript results, hepatic fibrosis, granulocyte and agranulocyte adhesion, and diapedesis were the top overrepresented pathways. Eighteen proteins correlated with the modified Rodnan skin thickness score (MRSS). Soluble epidermal growth factor receptor was significantly down-regulated in dcSSc and showed the strongest negative correlation with the MRSS, being predictive of the score's course over time, whereas α1 -antichymotrypsin was significantly up-regulated in dcSSc and showed the strongest positive correlation with the MRSS. Furthermore, higher levels of cancer antigen 15-3 correlated with more severe ILD, based on findings of reduced forced vital capacity and higher scores of disease activity on high-resolution computed tomography. Only 14 genes showed significant differential expression in the same direction in serum protein and whole blood RNA gene expression analyses. CONCLUSION: Diffuse cutaneous SSc has a distinct serum protein profile with prominent dysregulation of proteins related to fibrosis and immune cell adhesion/diapedesis. The differential expression for most serum proteins in SSc is likely to originate outside the peripheral blood cells.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Bellocchi C, Ying J, Goldmuntz EA, et al. Large-Scale Characterization of Systemic Sclerosis Serum Protein Profile: Comparison to Peripheral Blood Cell Transcriptome and Correlations With Skin/Lung Fibrosis. Arthritis Rheumatol. 2021. PMID: 33131208. doi:10.1002/art.41570

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。